Noida, UP India (PressExposure) June 07, 2011 -- Obesity has developed into a major global epidemic during the past few years. Increased consumption of more energy-dense, nutrient poor foods with high levels of sugar and saturated fats, combined with reduced physical activity, have resulted in obesity rates that have risen three-fold or more since 1980 all around the globe. With such stupendous rise in the prevalence rate, the demand for obesity drugs will also rise. Due to this, the global obesity market is expected to grow at a CAGR of around 13% during 2012 - 2013, says our new research report "Global Obesity Drug Market Analysis".
Moreover, our team of experts has found out various reasons that will fuel the growth of the market in near future. Along with rising concerns towards health and increasing consumer spending on healthcare services, various other factors, which will help in the growth of the market, like government support, focus on new emerging treatments have also been discussed in our report. The main reason for the huge government support towards the obesity market is the cost associated with obesity and associated diseases, which pose a burden over government's total healthcare spending.
Our report has covered developments taking place around all the major countries of the world on the basis of prevalence of obesity in the respective country. The countries have been grouped on the regional basis into North America, Latin America, Europe, Asia Pacific, and the MEA region. Most importantly, detail description of the blockbuster drugs for the obesity treatment as well as the future drug pipeline has also been discussed in detail in our report.
"Global Obesity Drug Market Analysis" provides thorough research and rational analysis along with reliable statistics of the global obesity drug market. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the regional obesity market across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, and segmentation have been thoroughly studied in the report to present a comprehensive view of the global obesity drug market. The report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.
For FREE SAMPLE of this report visit: [http://rncos.com/Report/IM335.htm]
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm